Close

Industry Reports

Pfizer Completes Acquisition of Medivation Inc

Pfizer Inc announced the successful completion of its acquisition of Medivation, Inc . As of the tender offer expiration, 115,574,041 shares of Medivation common stock were validly tendered, representing approximately 69.1% of the shares outstanding and have been accepted...

Sonoco ThermoSafe Acquires AAR Cold Chain Solutions Assets

Sonoco ThermoSafe has acquired the PharmaPort 360â„¢ assets, licenses, trademarks and manufacturing rights from AAR, to enter the active temperature-controlled cargo containers market. Sonoco ThermoSafe will own and lease the PharmaPort 360 containers globally while signing...

Klöckner Pentaplast acquires the packaging company from Farmamak Review Initiative

The global rigid film producer Klöckner Pentaplast will acquire Farmamak Review from Venture Capital Investment Trust Inc. (Review Initiative). Farmamak will operat on as a subsidiary within the Klöckner Pentaplast Group.  Klöckner Pentaplast, a world-leading producer...

Amcor Announces Result For Year Ended 30 June 2016

In announcing the result, Amcor’s Managing Director & CEO, Mr Ron Delia said: “, Amcor reported a strong full year result with growth in earnings, returns and cash flow delivered in a challenging macroeconomic environment. Underlying...

Ball Corporation Publishes 2016 Sustainability Report

Ball Corporation published its fifth biennial sustainability report, which details the company's progress toward its updated priorities – product stewardship, operational excellence, talent management and community ambassadors – and sets a clear path for the future with 10 new...

Pfizer to buy antibiotics business from AstraZeneca

Pfizer Inc announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage small molecule anti-infectives business, primarily outside the United States. The agreement includes the commercialization...

Bayer Second quarter of 2016: Bayer raises sales and earnings:

Group sales increase by 2.3 percent (Fx & portfolio adj.) to EUR 11,833 million / Pharmaceuticals continues strong growth trend / Consumer Health increases sales / Crop Science business holds steady in a continuingly difficult market environment / EBITDA...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read